Results 331 to 340 of about 14,898,836 (369)

Standardization of Factor IX: Standards for "Purified" Factor IX Concentrates

Thrombosis and Haemostasis, 1991
SummaryAn international collaborative study was carried out to determine the suitability of the current WHO II-IX-X concentrate standard, 84/681, for assigning potency to the more highly purified factor IX concentrates. Three Coagulation Factor IX (Human) preparations and one Factor IX Complex preparation were assayed by the one stage method against ...
M A, Lamb, W A, Fricke, S C, Rastogi
openaire   +2 more sources

Heterogeneity of factor IX BM difference of cleavage sites by factor XIa and Ca2+in factor IX Kashihara, Factor IX Nagoya and Factor IX Niigata

Thrombosis Research, 1986
Abnormal factor IX was isolated from the plasma of a patient with hemophilia B Kashihara and two patients with hemophilia BM. The F.IX was purified to homogeneity by using monoclonal anti-F.IX-Sephrose, heparin-Sepharose and DEAE-Sephadex A-50 affinity chromatography successively.
A, Yoshioka, Y, Ohkubo, T, Nishimura, I, Tanaka, H, Fukui, K, Ogata, T, Kamiya, H, Takahashi   +7 more
openaire   +2 more sources

Factor IX complex for the correction of traumatic coagulopathy

Journal of Trauma and Acute Care Surgery, 2012
BACKGROUND: Damage control resuscitation advocates correction of coagulopathy; however, options are limited and expensive. The use of prothrombin complex concentrate (PCC), also known as factor IX complex, can quickly accelerate reversal of coagulopathy ...
B. Joseph, A. Amini, R. Friese, M. Houdek, D. Hays, N. Kulvatunyou, Julie L. Wynne, T. O'keeffe, R. Latifi, P. Rhee   +9 more
semanticscholar   +1 more source

Factor IX and thrombosis

Scandinavian Journal of Haematology, 1977
Fractionation technology has made Factor IX concentrates available. In addition to a very high incidence of hepatitis, thrombosis is being recognized as a consequence of their use. Contradictory reports exist in the literature as to the incidence of thrombotic events.
openaire   +2 more sources

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

Nature Medicine, 2006
C. Manno, V. Arruda, G. Pierce, B. Glader, M. Ragni, J. Rasko, Margareth C. Ozelo, K. Hoots, P. Blatt, B. Konkle, M. Dake, R. Kaye, M. Razavi, A. Zajko, J. Zehnder, H. Nakai, A. Chew, D. Leonard, D. Leonard, J. F. Wright, R. Lessard, J. Sommer, M. Tigges, D. Sabatino, A. Luk, Haiyan Jiang, F. Mingozzi, L. Couto, H. Ertl, Katherine A. High, Katherine A. High, M. Kay   +31 more
semanticscholar   +1 more source

Factor IX activity and factor IX antigen in haemophilia B carriers

Thrombosis Research, 1975
Abstract Examinations performed on the female relatives of haemophilia B patients suggest that factor IX activity is significantly reduced in the carriers of haemophilia B. In the carriers of haemophilia B− the amount of factor IX antigen is in correlation with factor IX activity, while in the carriers of the B+ variant the amount of factor IX ...
openaire   +2 more sources

Clinical use of recombinant factor VIII Fc and recombinant factor IX Fc in patients with haemophilia A and B

Haemophilia, 2018
C. Wang, G. Young
semanticscholar   +1 more source

Factor IX Concentrates

Thrombosis and Haemostasis, 1975
openaire   +2 more sources

Factor IX Complex

Seminars in Thrombosis and Hemostasis, 1980
openaire   +2 more sources

Factor IX

Reactions Weekly, 1991
openaire   +2 more sources